Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

RLT

24 posts
NNovartis
BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset
Read More

BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset

  • 2026-09-22
SUZHOU, China, Sept. 22, 2026 /PRNewswire/ — Boomray Pharmaceuticals Co., Ltd. (“BoomRay”), a clinical-stage biotechnology company pioneering innovative…
NNovartis
Samsung Newsroom
Read More

Novartis to Invest 140 Billion Won in Korea’s Radioligand Therapy Supply Chain

  • 2026-07-21
Health and Welfare Minister Jung Eun-kyeong (left) and Judith Love, President of Novartis Asia Pacific, Middle East and…
NNovartis
Meet Colin: A Novartis Scientist Looking for New Breakthroughs
Read More

Meet Colin: A Novartis Scientist Looking for New Breakthroughs

  • 2026-07-11
Colin works in San Diego, where we’ve recently broken ground on a new, state-of-the-art global Biomedical Research center…
NNovartis
Carter’s Story: My Mom's Journey with Cancer Inspired Me. Now I Help Make Medicines for Patients
Read More

Carter’s Story: My Mom’s Journey with Cancer Inspired Me. Now I Help Make Medicines for Patients

  • 2026-06-05
Carter Jaynes, one of our RLT production managers, recently made a move across the country: He brought his…
NNovartis
Pushing the prostate cancer treatment frontier: Radioligand therapy and beyond
Read More

Pushing the prostate cancer treatment frontier: Radioligand therapy and beyond

  • 2026-05-28
Radioligand therapy (RLT) has been a breakthrough, practice-changing therapy in prostate cancer. While it has improved outcomes, Novartis…
NNovartis
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
Read More

Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA

  • 2026-05-27
Novartis Pharma AG Pluvicto® PSMAddition oral presentation to highlight efficacy outcomes by disease volume and de novo/recurrent metastatic…
NNovartis
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
Read More

Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

  • 2026-05-27
Novartis Pharma AG At one-year mark, company has progressed all components of US investment plan to support delivery…
NNovartis
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
Read More

Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities

  • 2026-05-25
Novartis Pharma AG US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark…
NNovartis
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
Read More

Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA

  • 2026-05-21
Pluvicto®PSMAddition oral presentation to highlight efficacy outcomes by disease volume and de novo/recurrent metastatic hormone-sensitive prostate cancer Kisqali®…
NNovartis
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
Read More

Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA

  • 2026-05-21
Novartis Pharma AG Pluvicto® PSMAddition oral presentation to highlight efficacy outcomes by disease volume and de novo/recurrent metastatic…
NNovartis
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
Read More

Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities

  • 2026-05-19
Novartis Pharma AG US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark…
NNovartis
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
Read More

Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities

  • 2026-05-19
Novartis Pharma AG US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark…
Switzerland
www.europesays.com